Holsinger Leslie
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Holsinger Leslie. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| QNCX | EVP, Preclinical Development | Tax Withholding | 10,920 | $2.86 | $31,231 | Jun 6, 2022 |
| QNCX | EVP, Preclinical Development | Award / Grant | 155,500 | — | — | Mar 3, 2022 |
| QNCX | Executive Vice President | Sale | 900 | $32.59 | $29,331 | Dec 14, 2020 |
| QNCX | Executive Vice President | Option Exercise | 3,500 | $0.27 | $945 | Dec 10, 2020 |